The investment seeks long-term growth of capital... Show more
The ARK Innovation ETF (ARKK) is an actively managed exchange-traded fund that seeks long-term capital growth by investing primarily in companies relevant to the theme of disruptive innovation. Unlike index-tracking funds, ARKK does not follow a benchmark; portfolio managers at ARK Invest select high-conviction holdings across genomics, automation, energy transformation, artificial intelligence, and next-generation internet technology. The fund is non-diversified and carries an expense ratio of 0.75%.
Its sector allocation is heavily weighted toward healthcare (roughly 28% to 30%), technology (about 25%), financial services (around 15% to 16%), and consumer cyclical (near 13%), with smaller exposure to communication services and industrials. Geographically, the portfolio is overwhelmingly U.S.-centric, typically exceeding 75% of assets, with smaller positions in Switzerland, Canada, and Taiwan.
Top holdings have historically included Tesla, Tempus AI, Advanced Micro Devices, CRISPR Therapeutics, Robinhood, Coinbase, Shopify, and Twist Bioscience, alongside private and recently public names such as SpaceX. This concentration in growth-stage and, in many cases, unprofitable companies gives the fund a high beta and elevated volatility relative to the broader market. Structurally, that means ARKK's future performance potential is tied less to near-term profitability and more to the pace of technology adoption, innovation breakthroughs, and the cost of capital that investors apply to distant cash flows.
Several developments could materially shape ARKK's trajectory in the months ahead. The first is monetary policy. The Federal Reserve's rate path, and particularly the direction of long-dated Treasury yields, directly influences the discount rates applied to the fund's long-duration holdings. A sustained move higher in yields would compress valuations across the genomics and fintech sleeves, while a decline below recent levels has historically supported a re-rating of unprofitable growth.
Inflation data represents a closely watched trigger. Hotter-than-expected prints would reinforce a higher-for-longer stance and weigh on high-multiple equities, whereas softer readings could revive expectations for easing and support the portfolio.
Earnings and product milestones at Tesla are pivotal given the stock's roughly 10% weighting. Quarterly delivery figures, margin trends, and progress on full self-driving and robotaxi ambitions directly affect the fund's largest position.
The cryptocurrency cycle is another catalyst. ARKK's fintech cluster is sensitive to digital-asset prices, exchange volumes, and regulatory developments, meaning shifts in crypto sentiment can ripple through several top holdings. In the genomics segment, clinical trial results and regulatory decisions at companies such as CRISPR Therapeutics and Twist Bioscience can drive outsized moves in a short period. Finally, ETF flow trends themselves matter: sharp inflows or outflows can reinforce momentum in an actively traded, high-volatility fund.
ARKK operates at the intersection of the technology, healthcare, and financial sectors, making it unusually sensitive to the broader macro outlook. The dominant theme in 2026 has been a concentrated technology rally led by semiconductor, memory, and data-center infrastructure names tied directly to artificial intelligence. While ARKK holds AMD and emerging AI-adjacent positions, its exposure to the hardware leaders of this cycle is comparatively limited, which has affected its relative performance.
Interest rates remain the most important macro transmission mechanism. The fund's holdings generally throw off minimal current earnings, so their valuations behave mechanically with long-dated yields. Persistent inflation above the central bank's target, combined with a cautious Federal Reserve, would keep discount rates elevated and constrain multiple expansion. Conversely, a credible shift toward easing would disproportionately benefit the fund's unprofitable-growth and biotech segments.
Beyond rates, the economic growth backdrop influences consumer-facing positions such as Shopify and Robinhood, while the genomics and precision-medicine themes are driven more by scientific progress and regulatory pathways than by the business cycle. Globally, the fund's heavy U.S. concentration means the trajectory of domestic equities, dollar strength, and risk appetite are the primary drivers, with emerging-market and international exposure playing a minor role.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders and investors assess whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the coming week or month. The tool is built to identify developing trends, evaluate potential breakouts or reversals, and surface predictions across a broad universe of tradable instruments. With searchable prediction categories, historical context, and alert-oriented functionality, it offers a data-driven complement to traditional fundamental and technical analysis. For those monitoring ARKK's evolving outlook, the Trend Prediction Engine provides an additional lens for gauging short- to medium-term directional signals.
Over a multi-year horizon, ARKK's fortunes are anchored to several durable structural themes. The continued build-out of artificial intelligence infrastructure, the falling cost of genomic sequencing, advances in autonomous and electric mobility, the expansion of digital-asset infrastructure, and the commercialization of space remain long-running innovation drivers. These secular forces do not move in a straight line, and their market leadership can rotate sharply between cycles.
The fund's long-term outlook is also shaped by the interest-rate cycle. As a high-beta, long-duration portfolio, ARKK has historically performed best in falling-rate environments and struggled during periods of restrictive policy. Demographic and market-structure shifts, including the growth of active thematic investing and retail participation in innovation strategies, continue to influence demand for the fund. The sustainability of its holdings' cash-burn rates, the pace at which promising technologies reach commercial scale, and the resolution of regulatory questions in biotech and digital assets will collectively determine whether the fund's high-conviction, concentrated approach compounds value over time.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Category MidCapGrowth
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HERZ | 16.24 | 0.03 | +0.19% |
| Herzfeld Credit Income Fund Inc. | |||
| IBCA | 24.53 | N/A | N/A |
| iShares iBonds Dec 2035 Term Corp ETF | |||
| RCTR | 32.89 | -0.90 | -2.66% |
| First Trust Bloomberg Nuclear Power ETF | |||
| DTCR | 27.22 | -1.04 | -3.68% |
| Global X Data Center & Dgtl Infrs ETF | |||
| CHPS | 79.93 | -4.91 | -5.79% |
| Xtrackers Semiconductor Select Eq ETF | |||
A.I.dvisor indicates that over the last year, ARKK has been closely correlated with ARKW. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARKK jumps, then ARKW could also see price increases.
| Ticker / NAME | Correlation To ARKK | 1D Price Change % | ||
|---|---|---|---|---|
| ARKK | 100% | +0.63% | ||
| ARKW - ARKK | 94% Closely correlated | +0.50% | ||
| VXF - ARKK | 89% Closely correlated | +0.68% | ||
| ARKQ - ARKK | 85% Closely correlated | +0.72% | ||
| KOMP - ARKK | 84% Closely correlated | +1.10% | ||
| IWP - ARKK | 81% Closely correlated | +0.97% | ||
More | ||||
The 10-day RSI Indicator for ARKK moved out of overbought territory on August 24, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 instances where the indicator moved out of the overbought zone. In 30 of the 33 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARKK as a result. In 79 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ARKK turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 47 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARKK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
ARKK broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
ARKK moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ARKK crossed bullishly above the 50-day moving average on August 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +4.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARKK advanced for three days, in 269 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 212 of 241 cases where ARKK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.